Cambridge Cognition wins eCOA contract worth over £500,000

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a contract worth over £500,000 to provide electronic clinical outcome assessments to support a major pharmaceutical client in delivering a Phase II paediatric study over several years. This is the second eCOA contract Cambridge Cognition has secured with the Client in just over a year. The first was of a similar value and referenced in the Company’s trading update on 30 June 2020.  

To support the Client in establishing the safety and efficacy of a new drug, the Company will collect patients’ and parents’ experiences with electronic questionnaires, scales and diaries. This data will be collected both in clinics on iPads and at home on smartphones using Cambridge Cognition’s eCOA system. Cambridge Cognition’s experienced study management team will work closely with the Client to ensure successful use of the software and devices. 

The provision of eCOA for clinical trials is a sizeable growth market, valued at over US$1bn per annum and growing at 15% according to market research reports1.  Cambridge Cognition provides eCOA solutions primarily for clinical trials for central nervous systems disorders, such as Alzheimer’s disease, although can also support other conditions.

Matthew Stork, Chief Executive Officer of Cambridge Cognition, said:

“At Cambridge Cognition, we pride ourselves on our customer service and I am pleased to see this recognised with repeat custom from a major pharmaceutical client.  In addition, it is a success for our commercialisation strategy as it again shows that our eCOA solution can be a standalone product, as well as an upsell with cognitive assessments for clinical trials.”

1. Grand View Research, Electronic Clinical Outcome Assessment Solutions Market, 2018

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Cambridge Cognition Holdings

More articles like this

Cambridge Cognition Holdings

Cambridge Cognition forms new Scientific Advisory Board

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, is pleased to announce the formation of a Scientific Advisory Board. This expert board will provide scientific guidance and valuable market insights, primarily focusing

Cambridge Cognition Holdings

Cambridge Cognition Holdings Changes its Auditor to Crowe UK LL

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Board has approved the appointment of Crowe UK LLP as the Group’s new external auditor following a competitive

Cambridge Cognition Holdings

Cambridge Cognition strengthens balance sheet with £3 million loan

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Company has obtained a £3.0 million loan from Claret European Specialty Lending Company III, S.à r.l.  Claret specialises in

Cambridge Cognition Holdings

Cambridge Cognition Holdings Revision to Explanatory Note

Cambridge Cognition (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the explanatory note to Resolution 7 in the Notice of the Annual General Meeting (“AGM”) to be held on 28 June 2023

Cambridge Cognition Holdings

Cambridge Cognition publishes Annual Report and Accounts

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has confirmed that the Annual Report and Accounts for the year ended 31 December 2022 and the Notice of the Annual General

Cambridge Cognition Holdings

Cambridge Cognition growth strategy clearly paying off (VIDEO)

Cambridge Cognition Holdings plc (LON:COG) CEO Matthew Stork joins DirectorsTalk Interviews to discuss prelim results for the year ended 31 December 2022. In this interview Matthew talks us through the result highlights, explains how the the acquisitions